Wells Fargo’s Sonoma Pharmaceuticals SNOA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-1
| Closed | -$3 | – | 7185 |
|
|
2024
Q3 | $3 | Sell |
1
-1
| -50% | -$5 | ﹤0.01% | 6814 |
|
|
2024
Q2 | $7 | Sell |
2
-4
| -67% | -$14 | ﹤0.01% | 6686 |
|
|
2024
Q1 | $20 | Buy |
6
+1
| +20% | +$3 | ﹤0.01% | 7119 |
|
|
2023
Q4 | $19 | Buy |
5
+3
| +150% | +$19 | ﹤0.01% | 7242 |
|
|
2023
Q3 | $29 | Hold |
2
| – | – | ﹤0.01% | 7084 |
|
|
2023
Q2 | $35 | Buy |
2
+1
| +100% | +$21 | ﹤0.01% | 7151 |
|
|
2023
Q1 | $21 | Hold |
1
| – | – | ﹤0.01% | 7353 |
|
|
2022
Q4 | $24 | Hold |
1
| – | – | ﹤0.01% | 7241 |
|
|
2022
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 7297 |
|
|
2022
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 7427 |
|
|
2022
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 7745 |
|
|
2021
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 7754 |
|
|
2021
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 7465 |
|
|
2021
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 7388 |
|
|
2021
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 7327 |
|
|
2020
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 6971 |
|
|
2020
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 6848 |
|
|
2020
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 6766 |
|
|
2020
Q1 | $0 | Buy |
+1
| New | +$101 | ﹤0.01% | 6740 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 6596 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 6412 |
|
|
2018
Q2 | – | Sell |
-6
| Closed | -$4K | – | 6541 |
|
|
2018
Q1 | $4K | Hold |
6
| – | – | ﹤0.01% | 6106 |
|
|
2017
Q4 | $6K | Hold |
6
| – | – | ﹤0.01% | 6025 |
|
|
2017
Q3 | $5K | Hold |
6
| – | – | ﹤0.01% | 6031 |
|
|
2017
Q2 | $7K | Hold |
6
| – | – | ﹤0.01% | 5855 |
|
|
2017
Q1 | $7K | Hold |
6
| – | – | ﹤0.01% | 5968 |
|
|
2016
Q4 | $5K | Hold |
6
| – | – | ﹤0.01% | 5959 |
|
|
2016
Q3 | $4K | Sell |
6
-6
| -50% | -$4.51K | ﹤0.01% | 5960 |
|
|
2016
Q2 | $9K | Buy |
12
+5
| +71% | +$4.31K | ﹤0.01% | 5698 |
|
|
2016
Q1 | $6K | Hold |
7
| – | – | ﹤0.01% | 5843 |
|
|
2015
Q4 | $7K | Hold |
7
| – | – | ﹤0.01% | 5812 |
|
|
2015
Q3 | $9K | Hold |
7
| – | – | ﹤0.01% | 5738 |
|
|
2015
Q2 | $9K | Hold |
7
| – | – | ﹤0.01% | 5844 |
|
|
2015
Q1 | $5K | Hold |
7
| – | – | ﹤0.01% | 5817 |
|
|
2014
Q4 | $9K | Hold |
7
| – | – | ﹤0.01% | 5677 |
|
|
2014
Q3 | $15K | Buy |
7
+6
| +600% | +$14K | ﹤0.01% | 5428 |
|
|
2014
Q2 | $4K | Hold |
1
| – | – | ﹤0.01% | 5848 |
|
|
2014
Q1 | $5K | Hold |
1
| – | – | ﹤0.01% | 5545 |
|
|
2013
Q4 | $5K | Hold |
1
| – | – | ﹤0.01% | 5364 |
|
|
2013
Q3 | $4K | Hold |
1
| – | – | ﹤0.01% | 5337 |
|
|
2013
Q2 | $3K | Buy |
+1
| New | +$3.57K | ﹤0.01% | 5322 |
|
Other funds holding SNOA
TRCT
AF
DB
Wells Fargo's SNOA Position: Q4 2024 in Review
Wells Fargo sold out of Sonoma Pharmaceuticals (SNOA) in Q4 2024, closing a stake of 1 share — an estimated $3 sold.
Wells Fargo first reported a position in SNOA in Q2 2013 and held it in 39 quarters. The position peaked at $15K in Q3 2014. 9 funds tracked by Wall St. Rank hold SNOA as of Q4 2024.
- Wells Fargo reported no remaining Sonoma Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
- Wells Fargo sold 1 Sonoma Pharmaceuticals share in Q4 2024, an estimated $3.
- Wells Fargo first reported a position in Sonoma Pharmaceuticals in Q2 2013 and held it in 39 quarters.
- Wells Fargo's Sonoma Pharmaceuticals position peaked at $15K in Q3 2014.
- 9 funds tracked by Wall St. Rank held Sonoma Pharmaceuticals as of Q4 2024.
Based on Wells Fargo's 13F filing for Q4 2024, filed 13 Feb 2025.